Feb 27, 2013 – IntelliSyn aligns with Molecular Forecaster as strategic partners. Molecular Forecaster is an emerging leader in computational chemistry and in silico drug design. They provide tools and expertise in medicinal chemistry to academic and industrial research environments.
Jan 15, 2013 – IntelliSyn is named as a member organization of Pharmaqam; a consortium of 50 researchers from 17 different institutions with common interests in biopharmaceutical research. The center focuses on the molecular aspects of biopharmaceutical research and brings together complementary cutting-edge research essential for efficient drug discovery.http://www.pharmaqam.uqam.ca/
Nov 1, 2012 – IntelliSyn selected as a Med Chem and synthesis provider to a California-based mid-size pharmaceutical company.
July 15, 2012 – IntelliSyn selected as exclusive Med Chem partner for Epigenetix, a Miami-based biotechnology group focusing on novel epigenetic mechanisms for cancer and other indications. Epigenetix provides full medicinal chemistry design, synthesis, and DMPK support.